semaglutide hf Efficacy and safety of in patients with heart failure with preserved ejection fraction and obesity - Rehman - 2024 - Clinical Cardiology New Science Suggests Semaglutide Improves

Semaglutide is a GLP-1 receptor agonist that slows gastric emptying, reduces appetite, and increases feelings of fullness

Questions to Ask Yourself: Before Choosing Oral Semaglutide: Have I tried injectable GLP-1s

Novo Nordisk conducted fewer than 2 years worth of studies but heavily marketed Ozempic as a popular diabetes and weight loss drug

Novo Nordisk said the study did not take into account whether patients smoked or for how long they had had diabetes

For instance, certain microbial signatures could be associated with greater weight loss or stronger glycemic improvements

Long-term considerations start becoming relevant here